Key insight: A large study will test whether matching patients’ genetic variants to known drug responses before they need treatment will improve health and economic outcomes.
Dr. Richard Weinshilboum is asking a big question: What if your doctor knew which drugs to treat you with before you got sick?
Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!
GET STARTEDWhat is it?
STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- Online intelligence briefings
- Frequent opportunities to engage with veteran beat reporters and industry experts
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author
The problem with pharmacogenomics is that that it is not a perfect predictor. Every patient represents a therapeutic trial with n=1. The best doctors know how to mix and match drugs. If you extend the case for predictive genomics then every doctor would rely on a Watson super computer for the correct drug and dosage. Even if Watson were affordable I know a few doctors that would trust one like Dave trusted HAL in “2001”.